Center for Studying Health System Change

	J. Lee Hargraves
	Marie C. Reed

Print This Page Email This Page Download pdf

Share:

• twitterExpand
• Facebook
• digg
• Mixx It
• CiteULike
• Connotea
• Google Bookmarks
• Delicious

Prescription Drug Access Disparities Among Working-Age Americans

Issue Brief No. 73
December 2003
Marie C. Reed, J. Lee Hargraves

orking-age African Americans and Latinos are much more likely than white Americans to report they cannot afford all of their prescription drugs, according to a new study by the Center for Studying Health System Change (HSC). In 2001, nearly one in five blacks and one in six Latinos 18 to 64 years old did not purchase all of their prescriptions because of cost, compared with slightly more than one in 10 whites. Cost-related prescription drug access problems are considerably higher for people with chronic conditions,¹ particularly African Americans. Regardless of race or ethnicity, uninsured working-age people with chronic conditions are at particular risk for not being able to afford all of their prescriptions, with about half reporting cost-related prescription access problems. Increased patient cost sharing for prescription drugs will likely increase prescription drug access disparities for insured African Americans and Latinos, especially those with chronic conditions.

• Blacks and Latinos More Likely to Go Without Prescriptions
• Large Gap for Minorities with Chronic Conditions
• Gaps Exist Among Insured But Not Among Uninsured
• More Disparities?
• Notes
• Data Source
• Supplementary Tables

Blacks and Latinos More Likely to Go Without Prescriptions

pending on prescription drugs continues to increase rapidly in the United States, reflecting a growing reliance on drugs to treat a variety of health problems.Access to prescriptions varies by race. For example, research has shown that blacks are less likely to be prescribed medicines than are whites with similar health conditions.²

According to results from the Community Tracking Study (CTS) 2001 Household Survey (see Data Source), working-age African Americans and Latinos are considerably more likely than whites not to fill all of their prescriptions because of cost concerns (see Figure 1). Overall, about 20 percent of blacks, 16 percent of Latinos and 11 percent of non-Hispanic whites did not fill at least one prescription in 2001 because of cost concerns.

Back to Top

Large Gap for Minorities with Chronic Conditions

hronic conditions contribute substantially to racial and ethnic disparities in health status in the United States, particularly for African Americans, and are among the principal reasons why blacks die at younger ages and at a much higher rate than white Americans.³ Black Americans also are more likely to have multiple chronic conditions.⁴

Working-age African Americans and Latinos with chronic conditions were substantially more likely than whites to report not having filled at least one prescription in 2001 because of cost (see Table 1).More than 30 percent of blacks and a quarter of Latinos with chronic conditions didn’t purchase all of their prescriptions in 2001 because of cost, compared with 17 percent of whites living with chronic conditions.Workingage Latinos and blacks without chronic conditions were also more likely than whites to face prescription drug affordability problems. In general, however, people without chronic health problems are much less likely to report having problems purchasing their prescriptions.

Overall, the relative disparity in costrelated prescription drug access problems for African Americans and Latinos compared with whites is fairly similar regardless of the number of chronic conditions: blacks are about 75 percent and Latinos about 50 percent more likely than whites not to have purchased at least one prescription drug in 2001 because of cost issues. However, the absolute disparity or gap—the percentage point difference between the percent of whites and African Americans and Latinos with cost-related prescription drug access problems—is much greater for those with chronic conditions. This finding is important because prescription drugs are critical to ongoing treatment of many chronic conditions, and lack of access to appropriate prescription medication can result in pain,worsening of the condition and increased risk for other related health problems.

The size of the gap between minorities and whites in cost-related prescription drug access problems increases with the presence of chronic conditions. The gap between blacks and whites was 5 percentage points for those with no chronic conditions, 12 points for those with one condition and 15 points for people with multiple conditions. Similar, though generally smaller, gaps were found for Latinos as well. More than 35 percent of blacks and 30 percent of Latinos with multiple chronic conditions did not purchase all of their prescriptions in 2001 because of cost, compared with slightly more than 20 percent of whites.

Back to Top

Gaps Exist Among Insured But Not Among Uninsured

ninsured people were more than three times as likely as those with private health coverage to have gone without at least one prescription in 2001 because of cost concerns (see Table 2). However, previous HSC research shows that drug-affordability problems are not limited to the uninsured—about a quarter of working-age people with Medicaid or other state coverage did not purchase at least one prescription in 2001 because they could not afford it.⁵ African Americans and Latinos are more likely to be uninsured or to receive their health insurance through a public program⁶, and, as a result, members of these minority groups are more likely to have problems affording all of their prescriptions.

Uninsured African Americans, whites and Latinos were equally likely to report problems affording prescription drugs. All three groups had extremely high rates of affordability problems, particularly among those with chronic conditions. Regardless of race or ethnicity, about 50 percent of working-age uninsured people with chronic conditions reported cost-related prescription drug access problems. The rate for uninsured persons without chronic conditions was about half that level.

Similar to uninsured people, working-age people with public insurance, including Medicaid and Medicare, were more likely than privately insured people to report problems affording prescription drugs. In particular, publicly insured African Americans living with chronic conditions were much more likely than publicly insured whites or Latinos with chronic conditions to report problems affording all of their prescriptions. Even after accounting for socioeconomic factors such as income, age and gender that can affect both need and ability to pay, blacks with public insurance and at least one chronic condition were a third more likely than whites with public insurance and at least one chronic condition to have problems affording all of their prescription drugs.⁷ Some possible explanations for this disparity may include differences in individual and family financial pressures and resources as well as regional and individual factors not accounted for in the model.

Prescription drug access problems are lowest for the privately insured, regardless of race or ethnicity.However, significant racial and ethnic disparities in access to prescription drugs exist among those with private insurance, with the largest disparities among those with chronic conditions.Working-age, privately insured African Americans with chronic conditions were twice as likely as whites (22% compared with 11%) not to purchase all of their prescription drugs in 2001 because of cost concerns. Privately insured Latinos with chronic conditions (18%) also experienced more problems affording drugs than did whites. A prescription drug access gap also exists for privately insured African Americans and Latinos without chronic conditions.

There are a variety of explanations for these disparities, many of which are economic. For example, employed blacks and Latinos generally earn less than whites, and they are less likely to work for employers offering health plans with generous prescription benefits.And, if offered a choice of health plans, they may be more likely to select one with lower premiums—which generally provides fewer benefits and requires more patient cost sharing—to increase takehome pay.⁸ When income and other socioeconomic factors are taken into account, the prescription drug access gap for the privately insured with chronic conditions closes for Latinos but not for African Americans.

Back to Top

Table 1
Working-Age People Who Did Not Purchase at Least One Prescription Drug in 2001 Because of Cost by Number of Chronic Conditions¹

Table 2
Working-Age People Who Did Not Purchase at Least One Prescription Drug in 2001 Because of Cost by Chronic Condition Status¹ and Type of Insurance

More Disparities?

s private and public payers grapple with rising health care costs, including those related to drug price and volume increases, consumers are being asked to pay more for their prescription drugs in a variety of ways. Some have higher copayments, and most plans now include tiered copayments where patients pay more for brandname drugs and those not on a preferred list. Others have prescription drug coverage with coinsurance, where patients pay a percentage of the total drug cost rather than a fixed copayment. Price sensitivity to prescription purchases is strong, particularly among lowincome people, meaning that even minimal patient out-of-pocket costs can result in people failing to fill their prescriptions.⁹

African Americans and Latinos are much more likely to have lower incomes than are whites, putting them at greater risk for increased problems paying for their drugs as out-of-pocket costs escalate. And since African Americans and Latinos with chronic health conditions are much more likely than whites to have problems affording all of their prescription drugs already, prescription drug access disparities among those with chronic conditions are likely to increase as patient cost sharing increases. Rising out-ofpocket prescription drug costs may undercut efforts to reduce racial and ethnic disparities in access to health care, including prescription drugs,with the greatest effect on reduced access for minorities with chronic conditions.

Back to Top

Notes

Back to Top

Data Source

This Issue Brief presents findings from the HSC Community Tracking Study Household Survey, a nationally representative telephone survey of the civilian, noninstitutionalized population conducted in 2000-01. Data were supplemented by in-person interviews of households without telephones to ensure proper representation. The survey contains information on about 60,000 people, including approximately 37,000 white, Latino and African Americans 18 to 64 years of age. The response rate was 59 percent. Estimates in the Issue Brief reflect the percentage of working-age adults who responded "yes" to the following question: "During the past 12 months, was there any time you needed prescription medicines but didn’t get them because you couldn’t afford it?" More detailed information on survey methodology can be found on this Web site.

Back to Top

Supplementary Tables

Supplementary Table 1: Chronic Condition Status of Persons 18-64 by Race/Ethnic Group
Supplementary Table 2: Insurance Type of Persons 18-64 by Race/Ethnic Group
Supplementary Table 3: Adjusted Odds Ratios for Not Purchasing At Least One Prescription Drug in 2001 Because of Cost: Persons 18-64
Supplementary Table 4: Predicted Percentages of Persons 18-64 Not Purchasing at Least One Prescription Drug in 2001 Because of Cost

ISSUE BRIEFS are published by the Center for Studying Health System Change.

600 Maryland Avenue, SW, Suite 550
Washington, DC 20024-2512
Tel: (202) 484-5261
Fax: (202) 484-9258
www.hschange.org